Effect of Hepatitis C virus proteins on the production of proinflammatory and profibrotic cytokines in Huh7.5 human hepatoma cells


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Hepatitis C virus (HCV) is a widespread dangerous human pathogen. Up to 80% of HCV-infected individuals develop chronic infection, which is often accompanied by liver inflammation and fibrosis and, at terminal stages, liver cirrhosis and cancer. Treatment of patients with end-stage liver disease is often ineffective, and even patients with suppressed HCV replication have higher risk of death as compared with noninfected subjects. Therefore, investigating the mechanisms that underlie HCV pathogenesis and developing treatments for virus-associated liver dysfunction remain an important goal. The effect of individual HCV proteins on the production of proinflammatory and profibrotic cytokines in hepatocellular carcinoma Huh7.5 cells was analyzed in a systematic manner. Cells were transfected with plasmids encoding HCV proteins. Cytokine production and secretion was accessed by immunocytochemistry and ELISA of the culture medium, and transcription of the cytokine genes was assessed using reverse transcription and PCR. HCV proteins proved to differ in effect on cytokine production. Downregulation of interleukin 6 (IL-6) production was observed in cells expressing the HCV core, NS3, and NS5A proteins. Production of transforming growth factor β1 (TGF-β1) was lower in cells expressing the core proteins, NS3, or E1/E2 glycoproteins. A pronounced increase in production and secretion of tumor necrosis factor α (TNF-α) was observed in response to expression of the HCV E1/E2 glycoproteins. A higher biosynthesis, but a lower level in the cell culture medium, was detected for interleukin 1β (IL-1β) in cells harboring NS4 and IL-6 in cells expressing NS5В. The finding was possibly explained by protein-specific retention and consequent accumulation of the respective cytokines in the cell.

Об авторах

O. Masalova

Ivanovsky Institute of Virology, Gamaleya Research Center of Epidemiology and Microbiology

Автор, ответственный за переписку.
Email: ol.mas@mail.ru
Россия, Moscow, 123098

E. Lesnova

Ivanovsky Institute of Virology, Gamaleya Research Center of Epidemiology and Microbiology

Email: ol.mas@mail.ru
Россия, Moscow, 123098

K. Permyakova

Ivanovsky Institute of Virology, Gamaleya Research Center of Epidemiology and Microbiology

Email: ol.mas@mail.ru
Россия, Moscow, 123098

E. Samokhvalov

Ivanovsky Institute of Virology, Gamaleya Research Center of Epidemiology and Microbiology

Email: ol.mas@mail.ru
Россия, Moscow, 123098

A. Ivanov

Engelhardt Institute of Molecular Biology

Email: ol.mas@mail.ru
Россия, Moscow, 119991

S. Kochetkov

Engelhardt Institute of Molecular Biology

Email: ol.mas@mail.ru
Россия, Moscow, 119991

A. Kushch

Ivanovsky Institute of Virology, Gamaleya Research Center of Epidemiology and Microbiology

Email: ol.mas@mail.ru
Россия, Moscow, 123098

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Pleiades Publishing, Inc., 2016

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).